Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)
[X]
Rule 12g-4(a)(2)
[ ]
Rule 12h-3(b)(1)(i)
[X]
Rule 12h-3(b)(1)(ii)
[ ]
Rule 15d-6
[ ]
Approximate number of holders of record as of the certification or notice date:
Common Stock: One Hundred Sixty (160)
Pursuant to the requirements of the Securities Exchange Act of 1934, Rejuvel Bio-Sciences, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.